Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00661453 · ClinicalTrials.gov registry record · Phase 1
CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I
A Phase 1 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT00661453 is a Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 40 participants.
The verdict
NCT00661453, a Phase 1 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a multi-center trial to test safety and evaluate early treatment intervention with valproic acid and carnitine in moderating SMA symptoms of Type I infants.
Interventions
- DRUG Valproic Acid and Levocarnitine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-04 |
| Est. Completion | 2012-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00661453
The ClinicalTrials.gov registry entry for NCT00661453 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Valproic Acid and Levocarnitine is the first listed.
NCT00661453 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00661453 about?
NCT00661453 is a clinical study titled "CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I". This is a multi-center trial to test safety and evaluate early treatment intervention with valproic acid and carnitine in moderating SMA symptoms of Type I infants.
What is the current status of trial NCT00661453?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2008-04. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00661453?
The interventions under investigation include: Valproic Acid and Levocarnitine (DRUG).
Who is sponsoring clinical trial NCT00661453?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.